Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)
Victoria Florea(Bristol-Myers Squibb (United States)), Joshua M. Hare(University of Miami Health System), Mauricio G. Cohen(Santa Ana College), Angela C. Rieger(University of Miami), Muzammil Mushtaq, Eduard Ghersin(Rambam Health Care Campus), Roberto Miki(University of Miami), Aisha Khan(University of Miami), Cindy Delgado(University of Miami), Darcy L. DiFede(University of Miami), Jill El-Khorazaty(Emmes (United States)), Lina V. Caceres(MACOM (United States)), Ana Marie Landin(University of Miami), Raul D. Mitrani(University of Miami), Fouad Abuzeid(University of Miami), Ivonne Hernandez Schulman, Bryon A. Tompkins(MACOM (United States)), Krystalenia Valasaki(University of Miami), Alan W. Heldman(University of Miami), Adam Mendizabal(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Russell Saltzman(University of Miami), Samuel Golpanian(University of Miami), John Byrnes(SRI International), Daniel DaFonseca(MACOM (United States)), Makoto Natsumeda(MACOM (United States)), Maureen H. Lowery(University of Miami), Monisha N. Banerjee(MACOM (United States)), Marietsy V. Pujol(University of Miami), Robert C. Hendel, Kevin Ramdas(MACOM (United States)), Mayra Vidro-Casiano(University of Miami)
Cited by 204
Related Papers
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
US Renal Data System 2020 Annual Data Report: Epidemiology of Kidney Disease in the United States
|American Journal of Kidney Diseases|2021|727
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664